Acumen Pharmaceuticals, Inc.
|
ABOS
|
Unlock Forecast
|
$93M
|
-1.9x
|
0.8x
|
Abpro Holdings, Inc.
|
ABP
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Abpro Holdings, Inc.
|
ABPWW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Arcellx, Inc.
|
ACLX
|
Unlock Forecast
|
$3725M
|
-74.1x
|
8.9x
|
Alpha Cognition Inc.
|
ACOG
|
Unlock Forecast
|
$130M
|
x
|
4.1x
|
Adaptimmune Therapeutics PLC
|
ADAP
|
Unlock Forecast
|
$91M
|
-13.2x
|
-11.8x
|
ADMA BIOLOGICS, INC.
|
ADMA
|
Unlock Forecast
|
$4374M
|
20.9x
|
11.0x
|
Adaptive Biotechnologies Corp
|
ADPT
|
Unlock Forecast
|
$1977M
|
-4.6x
|
11.0x
|
Adverum Biotechnologies, Inc.
|
ADVM
|
Unlock Forecast
|
$58M
|
-1.8x
|
2.2x
|
AGENUS INC
|
AGEN
|
Unlock Forecast
|
$136M
|
-0.5x
|
-0.5x
|
AIM ImmunoTech Inc.
|
AIM
|
Unlock Forecast
|
$2M
|
-0.5x
|
-183.3x
|
AIM ImmunoTech Inc.
|
AIMI
|
Unlock Forecast
|
$2M
|
x
|
x
|
Alector, Inc.
|
ALEC
|
Unlock Forecast
|
$255M
|
-1.2x
|
3.6x
|
Aligos Therapeutics, Inc.
|
ALGS
|
Unlock Forecast
|
$96M
|
-19.2x
|
0.9x
|
Allogene Therapeutics, Inc.
|
ALLO
|
Unlock Forecast
|
$262M
|
-1.4x
|
0.8x
|
Kalaris Therapeutics, Inc.
|
ALVR
|
Unlock Forecast
|
$49M
|
-0.5x
|
0.4x
|
AMGEN INC
|
AMGN
|
Unlock Forecast
|
$158903M
|
24.0x
|
21.4x
|
Apogee Therapeutics, Inc.
|
APGE
|
Unlock Forecast
|
$2241M
|
-20.5x
|
4.3x
|
Aptose Biosciences Inc.
|
APTO
|
Unlock Forecast
|
$6M
|
0.0x
|
-1.3x
|
Aptose Biosciences Inc.
|
APTOF
|
Unlock Forecast
|
$3M
|
x
|
x
|
Armata Pharmaceuticals, Inc.
|
ARMP
|
Unlock Forecast
|
$97M
|
-1.0x
|
-1.6x
|
Artiva Biotherapeutics, Inc.
|
ARTV
|
Unlock Forecast
|
$70M
|
x
|
0.5x
|
Athira Pharma, Inc.
|
ATHA
|
Unlock Forecast
|
$16M
|
-0.2x
|
0.5x
|
Atara Biotherapeutics, Inc.
|
ATRA
|
Unlock Forecast
|
$143M
|
24.7x
|
-1.1x
|
aTYR PHARMA INC
|
ATYR
|
Unlock Forecast
|
$515M
|
-3.6x
|
6.9x
|
Aura Biosciences, Inc.
|
AURA
|
Unlock Forecast
|
$407M
|
-4.9x
|
2.3x
|
Autolus Therapeutics plc
|
AUTL
|
Unlock Forecast
|
$466M
|
x
|
1.3x
|
ANAVEX LIFE SCIENCES CORP.
|
AVXL
|
Unlock Forecast
|
$814M
|
-17.3x
|
9.0x
|
BioAtla, Inc.
|
BCAB
|
Unlock Forecast
|
$125M
|
-1.1x
|
1.0x
|
BioCardia, Inc.
|
BCDA
|
Unlock Forecast
|
$12M
|
-0.6x
|
-7.8x
|
BRAINSTORM CELL THERAPEUTICS INC.
|
BCLI
|
Unlock Forecast
|
$7M
|
-4.9x
|
-0.9x
|
BIOCRYST PHARMACEUTICALS INC
|
BCRX
|
Unlock Forecast
|
$1802M
|
-12.1x
|
-4.0x
|
Black Diamond Therapeutics, Inc.
|
BDTX
|
Unlock Forecast
|
$168M
|
11.6x
|
1.3x
|
Beam Therapeutics Inc.
|
BEAM
|
Unlock Forecast
|
$1677M
|
-12.6x
|
1.6x
|
BIOGEN INC.
|
BIIB
|
Unlock Forecast
|
$18125M
|
12.8x
|
1.5x
|
Black Hawk Acquisition Corp
|
BKHA
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Black Hawk Acquisition Corp
|
BKHAU
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
bluebird bio, Inc.
|
BLUE
|
Unlock Forecast
|
$49M
|
-0.2x
|
-0.8x
|
Cabaletta Bio, Inc.
|
CABA
|
Unlock Forecast
|
$148M
|
-1.6x
|
0.8x
|
Candel Therapeutics, Inc.
|
CADL
|
Unlock Forecast
|
$338M
|
-4.6x
|
4.5x
|
C4 Therapeutics, Inc.
|
CCCC
|
Unlock Forecast
|
$185M
|
-2.6x
|
1.1x
|
Cidara Therapeutics, Inc.
|
CDTX
|
Unlock Forecast
|
$728M
|
-1.0x
|
5.1x
|
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
|
CELZ
|
Unlock Forecast
|
$8M
|
-3.4x
|
1.2x
|
CERO THERAPEUTICS HOLDINGS, INC.
|
CERO
|
Unlock Forecast
|
$3M
|
x
|
-196.2x
|
CERO THERAPEUTICS HOLDINGS, INC.
|
CEROW
|
Unlock Forecast
|
$2M
|
x
|
-0.5x
|
Cullinan Therapeutics, Inc.
|
CGEM
|
Unlock Forecast
|
$449M
|
-4.1x
|
0.8x
|
COMPUGEN LTD
|
CGEN
|
Unlock Forecast
|
$136M
|
x
|
2.7x
|
CG Oncology, Inc.
|
CGON
|
Unlock Forecast
|
$2052M
|
x
|
3.1x
|
COGNITION THERAPEUTICS INC
|
CGTX
|
Unlock Forecast
|
$183M
|
-0.5x
|
26.0x
|
Pelthos Therapeutics Inc.
|
CHRO
|
Unlock Forecast
|
$8M
|
x
|
-2.0x
|
Coherus Oncology, Inc.
|
CHRS
|
Unlock Forecast
|
$143M
|
0.8x
|
1.2x
|
Calidi Biotherapeutics, Inc.
|
CLDI
|
Unlock Forecast
|
$6M
|
-0.9x
|
3.3x
|
Compass Therapeutics, Inc.
|
CMPX
|
Unlock Forecast
|
$418M
|
-4.8x
|
4.5x
|
Coeptis Therapeutics Holdings, Inc.
|
COEPW
|
Unlock Forecast
|
$M
|
x
|
x
|
Caribou Biosciences, Inc.
|
CRBU
|
Unlock Forecast
|
$172M
|
-1.5x
|
1.0x
|
Cardiff Oncology, Inc.
|
CRDF
|
Unlock Forecast
|
$154M
|
-4.0x
|
2.6x
|
CARGO Therapeutics, Inc.
|
CRGX
|
Unlock Forecast
|
$215M
|
x
|
0.9x
|
CURIS INC
|
CRIS
|
Unlock Forecast
|
$18M
|
-0.3x
|
-2.9x
|
CRISPR Therapeutics AG
|
CRSP
|
Unlock Forecast
|
$4801M
|
-12.1x
|
2.8x
|
CHAMPIONS ONCOLOGY, INC.
|
CSBR
|
Unlock Forecast
|
$111M
|
-17.8x
|
20.4x
|
CEL SCI CORP
|
CVM
|
Unlock Forecast
|
$51M
|
-0.9x
|
7.2x
|
Cyclo Therapeutics, Inc.
|
CYTH
|
Unlock Forecast
|
$26M
|
-0.6x
|
-1.9x
|
Cyclo Therapeutics, Inc.
|
CYTHW
|
Unlock Forecast
|
$7M
|
x
|
-0.5x
|
DBV Technologies S.A.
|
DBVT
|
Unlock Forecast
|
$1479M
|
-3.3x
|
514.8x
|
Ginkgo Bioworks Holdings, Inc.
|
DNA
|
Unlock Forecast
|
$568M
|
-13.9x
|
0.3x
|
Denali Therapeutics Inc.
|
DNLI
|
Unlock Forecast
|
$2111M
|
-8.7x
|
1.9x
|
PRECISION BIOSCIENCES INC
|
DTIL
|
Unlock Forecast
|
$58M
|
-2.2x
|
1.7x
|
DYADIC INTERNATIONAL INC
|
DYAI
|
Unlock Forecast
|
$28M
|
-7.3x
|
11.4x
|
Editas Medicine, Inc.
|
EDIT
|
Unlock Forecast
|
$231M
|
-0.8x
|
3.7x
|
Elevation Oncology, Inc.
|
ELEV
|
Unlock Forecast
|
$22M
|
-1.0x
|
0.5x
|
ELUTIA INC.
|
ELUT
|
Unlock Forecast
|
$94M
|
-1.4x
|
-0.1x
|
enGene Holdings Inc.
|
ENGN
|
Unlock Forecast
|
$221M
|
3.7x
|
1.0x
|
enGene Holdings Inc.
|
ENGNW
|
Unlock Forecast
|
$37M
|
x
|
0.1x
|
Entera Bio Ltd.
|
ENTX
|
Unlock Forecast
|
$91M
|
8.5x
|
5.3x
|
ENZO BIOCHEM INC
|
ENZ
|
Unlock Forecast
|
$25M
|
-3.0x
|
0.5x
|
ENZO BIOCHEM INC
|
ENZB
|
Unlock Forecast
|
$37M
|
x
|
0.8x
|
Estrella Immunopharma, Inc.
|
ESLA
|
Unlock Forecast
|
$36M
|
-3.1x
|
-16.9x
|
Estrella Immunopharma, Inc.
|
ESLAW
|
Unlock Forecast
|
$4M
|
x
|
5.3x
|
EXELIXIS, INC.
|
EXEL
|
Unlock Forecast
|
$11059M
|
18.4x
|
5.4x
|
EXOZYMES INC.
|
EXOZ
|
Unlock Forecast
|
$78M
|
x
|
10.8x
|
FATE THERAPEUTICS INC
|
FATE
|
Unlock Forecast
|
$136M
|
-1.3x
|
0.5x
|
4D Molecular Therapeutics, Inc.
|
FDMT
|
Unlock Forecast
|
$396M
|
-3.0x
|
0.9x
|
FENNEC PHARMACEUTICALS INC.
|
FENC
|
Unlock Forecast
|
$232M
|
1758.3x
|
-39.7x
|
Finch Therapeutics Group, Inc.
|
FNCH
|
Unlock Forecast
|
$20M
|
-0.1x
|
1.4x
|
FutureTech II Acquisition Corp.
|
FTII
|
Unlock Forecast
|
$-26M
|
x
|
-0.7x
|
FutureTech II Acquisition Corp.
|
FTIIU
|
Unlock Forecast
|
$-26M
|
x
|
-0.8x
|
FutureTech II Acquisition Corp.
|
FTIIW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
GILEAD SCIENCES, INC.
|
GILD
|
Unlock Forecast
|
$144266M
|
22.9x
|
7.3x
|
Monte Rosa Therapeutics, Inc.
|
GLUE
|
Unlock Forecast
|
$400M
|
16.5x
|
1.5x
|
Genenta Science S.p.A.
|
GNTA
|
Unlock Forecast
|
$64M
|
x
|
5.1x
|
Green Planet Bio Engineering Co. Ltd.
|
GPLB
|
Unlock Forecast
|
$M
|
x
|
x
|
HALOZYME THERAPEUTICS, INC.
|
HALO
|
Unlock Forecast
|
$9010M
|
16.2x
|
27.1x
|
HilleVax, Inc.
|
HLVX
|
Unlock Forecast
|
$103M
|
-0.6x
|
0.7x
|
Humacyte, Inc.
|
HUMA
|
Unlock Forecast
|
$247M
|
-3.3x
|
61.0x
|
Humacyte, Inc.
|
HUMAW
|
Unlock Forecast
|
$163M
|
x
|
-2.6x
|
ImmunityBio, Inc.
|
IBRX
|
Unlock Forecast
|
$2427M
|
-3.6x
|
-4.1x
|
Ikena Oncology, Inc.
|
IKNA
|
Unlock Forecast
|
$61M
|
-1.3x
|
0.5x
|
Inhibikase Therapeutics, Inc.
|
IKT
|
Unlock Forecast
|
$170M
|
-1.0x
|
2.1x
|
Immunocore Holdings plc
|
IMCR
|
Unlock Forecast
|
$1659M
|
x
|
4.3x
|
Immunovant, Inc.
|
IMVT
|
Unlock Forecast
|
$2607M
|
-14.5x
|
4.3x
|
IN8BIO, INC.
|
INAB
|
Unlock Forecast
|
$21M
|
-0.4x
|
2.4x
|
Inhibrx Biosciences, Inc.
|
INBX
|
Unlock Forecast
|
$387M
|
-6.8x
|
5.6x
|
MiNK Therapeutics, Inc.
|
INKT
|
Unlock Forecast
|
$59M
|
-1.5x
|
-1.4x
|
Inmune Bio, Inc.
|
INMB
|
Unlock Forecast
|
$64M
|
-2.5x
|
2.2x
|
INTENSITY THERAPEUTICS, INC.
|
INTS
|
Unlock Forecast
|
$8M
|
-2.2x
|
3.6x
|
IOVANCE BIOTHERAPEUTICS, INC.
|
IOVA
|
Unlock Forecast
|
$920M
|
-4.5x
|
1.3x
|
Century Therapeutics, Inc.
|
IPSC
|
Unlock Forecast
|
$47M
|
-0.7x
|
0.2x
|
iTeos Therapeutics, Inc.
|
ITOS
|
Unlock Forecast
|
$393M
|
-2.8x
|
0.7x
|
Invivyd, Inc.
|
IVVD
|
Unlock Forecast
|
$62M
|
-0.4x
|
1.5x
|
EXOZYMES INC.
|
IZTC
|
Unlock Forecast
|
$99M
|
x
|
-27.5x
|
Jasper Therapeutics, Inc.
|
JSPR
|
Unlock Forecast
|
$48M
|
-3.2x
|
2.0x
|
Jasper Therapeutics, Inc.
|
JSPRW
|
Unlock Forecast
|
$3M
|
x
|
0.0x
|
Kalaris Therapeutics, Inc.
|
KLRS
|
Unlock Forecast
|
$47M
|
x
|
0.9x
|
Klotho Neurosciences, Inc.
|
KLTO
|
Unlock Forecast
|
$39M
|
x
|
3.7x
|
Klotho Neurosciences, Inc.
|
KLTOW
|
Unlock Forecast
|
$1M
|
x
|
0.4x
|
Kodiak Sciences Inc.
|
KOD
|
Unlock Forecast
|
$539M
|
-2.5x
|
7.7x
|
Kiromic Biopharma, Inc.
|
KRBPQ
|
Unlock Forecast
|
$0M
|
x
|
x
|
Krystal Biotech, Inc.
|
KRYS
|
Unlock Forecast
|
$4487M
|
30.6x
|
4.3x
|
Kymera Therapeutics, Inc.
|
KYMR
|
Unlock Forecast
|
$3541M
|
-17.8x
|
3.7x
|
Kyverna Therapeutics, Inc.
|
KYTX
|
Unlock Forecast
|
$166M
|
x
|
0.9x
|
LadRx Corp
|
LADX
|
Unlock Forecast
|
$M
|
x
|
x
|
Lineage Cell Therapeutics, Inc.
|
LCTX
|
Unlock Forecast
|
$267M
|
-4.7x
|
5.5x
|
LENZ Therapeutics, Inc.
|
LENZ
|
Unlock Forecast
|
$1140M
|
-6.7x
|
5.5x
|
Liminatus Pharma, Inc.
|
LIMN
|
Unlock Forecast
|
$0M
|
x
|
x
|
Lexeo Therapeutics, Inc.
|
LXEO
|
Unlock Forecast
|
$265M
|
-0.4x
|
1.9x
|
Maze Therapeutics, Inc.
|
MAZE
|
Unlock Forecast
|
$592M
|
x
|
2.3x
|
MeiraGTx Holdings plc
|
MGTX
|
Unlock Forecast
|
$693M
|
-3.4x
|
20.9x
|
Metagenomi, Inc.
|
MGX
|
Unlock Forecast
|
$72M
|
x
|
0.4x
|
Moderna, Inc.
|
MRNA
|
Unlock Forecast
|
$10550M
|
-3.2x
|
1.1x
|
NEUROCRINE BIOSCIENCES INC
|
NBIX
|
Unlock Forecast
|
$13787M
|
39.6x
|
5.1x
|
NKGen Biotech, Inc.
|
NKGN
|
Unlock Forecast
|
$4M
|
-0.1x
|
-0.2x
|
NKGen Biotech, Inc.
|
NKGNW
|
Unlock Forecast
|
$1M
|
x
|
0.0x
|
Neumora Therapeutics, Inc.
|
NMRA
|
Unlock Forecast
|
$262M
|
-3.9x
|
1.4x
|
NOVAVAX INC
|
NVAX
|
Unlock Forecast
|
$1391M
|
3.3x
|
37.0x
|
Ocugen, Inc.
|
OCGN
|
Unlock Forecast
|
$298M
|
-4.3x
|
18.7x
|
Omega Therapeutics, Inc.
|
OMGA
|
Unlock Forecast
|
$9M
|
-0.7x
|
0.8x
|
Omega Therapeutics, Inc.
|
OMGAQ
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
VivoSim Labs, INC.
|
ONVO
|
Unlock Forecast
|
$35M
|
-0.4x
|
95.9x
|
Outlook Therapeutics, Inc.
|
OTLK
|
Unlock Forecast
|
$73M
|
-0.2x
|
-2.3x
|
PALISADE BIO, INC.
|
PALI
|
Unlock Forecast
|
$4M
|
-0.2x
|
0.7x
|
Passage BIO, Inc.
|
PASG
|
Unlock Forecast
|
$24M
|
-0.6x
|
0.6x
|
Vaxcyte, Inc.
|
PCVX
|
Unlock Forecast
|
$4387M
|
-20.4x
|
1.4x
|
BiomX Inc.
|
PHGE
|
Unlock Forecast
|
$15M
|
1.5x
|
0.8x
|
Pluri Inc.
|
PLUR
|
Unlock Forecast
|
$-5M
|
-1.4x
|
-9.1x
|
Protalix BioTherapeutics, Inc.
|
PLX
|
Unlock Forecast
|
$129M
|
20.5x
|
2.6x
|
PharmaCyte Biotech, Inc.
|
PMCB
|
Unlock Forecast
|
$7M
|
-2.6x
|
0.2x
|
Prime Medicine, Inc.
|
PRME
|
Unlock Forecast
|
$477M
|
-1.5x
|
7.8x
|
PROKIDNEY CORP.
|
PROK
|
Unlock Forecast
|
$-68M
|
x
|
0.0x
|
Poseida Therapeutics, Inc.
|
PSTX
|
Unlock Forecast
|
$926M
|
-9.6x
|
10.6x
|
Pelthos Therapeutics Inc.
|
PTHS
|
Unlock Forecast
|
$M
|
x
|
x
|
QIAGEN N.V.
|
QGEN
|
Unlock Forecast
|
$11177M
|
x
|
3.1x
|
Quince Therapeutics, Inc.
|
QNCX
|
Unlock Forecast
|
$87M
|
-1.7x
|
7.5x
|
Replimune Group, Inc.
|
REPL
|
Unlock Forecast
|
$932M
|
-3.8x
|
2.2x
|
REPLIGEN CORP
|
RGEN
|
Unlock Forecast
|
$6531M
|
8219.1x
|
3.3x
|
REGENXBIO Inc.
|
RGNX
|
Unlock Forecast
|
$463M
|
-1.8x
|
2.2x
|
Relay Therapeutics, Inc.
|
RLAY
|
Unlock Forecast
|
$634M
|
-2.0x
|
1.0x
|
Revolution Medicines, Inc.
|
RVMD
|
Unlock Forecast
|
$7134M
|
-11.1x
|
3.4x
|
Revolution Medicines, Inc.
|
RVMDW
|
Unlock Forecast
|
$16M
|
x
|
0.0x
|
RECURSION PHARMACEUTICALS, INC.
|
RXRX
|
Unlock Forecast
|
$2138M
|
-4.7x
|
2.3x
|
SAB Biotherapeutics, Inc.
|
SABS
|
Unlock Forecast
|
$24M
|
-2.3x
|
1.1x
|
SAB Biotherapeutics, Inc.
|
SABSW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
Sana Biotechnology, Inc.
|
SANA
|
Unlock Forecast
|
$852M
|
-2.1x
|
7.0x
|
Scilex Holding Co
|
SCLX
|
Unlock Forecast
|
$62M
|
-0.4x
|
-0.3x
|
Scilex Holding Co
|
SCLXW
|
Unlock Forecast
|
$25M
|
x
|
-0.1x
|
Scinai Immunotherapeutics Ltd.
|
SCNI
|
Unlock Forecast
|
$5359M
|
-287.8x
|
-2577.2x
|
SANGAMO THERAPEUTICS, INC
|
SGMO
|
Unlock Forecast
|
$141M
|
-1.6x
|
7.2x
|
Solid Biosciences Inc.
|
SLDB
|
Unlock Forecast
|
$495M
|
-0.9x
|
1.7x
|
Silexion Therapeutics Corp
|
SLXN
|
Unlock Forecast
|
$4M
|
x
|
34.7x
|
Silexion Therapeutics Corp
|
SLXNW
|
Unlock Forecast
|
$866M
|
x
|
-189.1x
|
Senti Biosciences, Inc.
|
SNTI
|
Unlock Forecast
|
$51M
|
-1.1x
|
1.3x
|
Scholar Rock Holding Corp
|
SRRK
|
Unlock Forecast
|
$4069M
|
-18.5x
|
13.0x
|
Surrozen, Inc./DE
|
SRZN
|
Unlock Forecast
|
$98M
|
-0.5x
|
2.1x
|
Surrozen, Inc./DE
|
SRZNW
|
Unlock Forecast
|
$0M
|
x
|
0.0x
|
SUTRO BIOPHARMA, INC.
|
STRO
|
Unlock Forecast
|
$73M
|
-1.0x
|
-2.5x
|
SpringWorks Therapeutics, Inc.
|
SWTX
|
Unlock Forecast
|
$3539M
|
-9.9x
|
8.5x
|
Protara Therapeutics, Inc.
|
TARA
|
Unlock Forecast
|
$129M
|
-2.1x
|
0.9x
|
Tarsus Pharmaceuticals, Inc.
|
TARS
|
Unlock Forecast
|
$2417M
|
-12.4x
|
7.3x
|
TC BioPharm (Holdings) plc
|
TCBP
|
Unlock Forecast
|
$37M
|
x
|
34.5x
|
TC BioPharm (Holdings) plc
|
TCBPW
|
Unlock Forecast
|
$1M
|
x
|
1.0x
|
TC BioPharm (Holdings) plc
|
TCBPY
|
Unlock Forecast
|
$21M
|
x
|
19.1x
|
TScan Therapeutics, Inc.
|
TCRX
|
Unlock Forecast
|
$243M
|
-4.6x
|
1.4x
|
BIO-TECHNE Corp
|
TECH
|
Unlock Forecast
|
$8155M
|
75.2x
|
4.0x
|
Tectonic Therapeutic, Inc.
|
TECX
|
Unlock Forecast
|
$490M
|
-8.9x
|
1.7x
|
Instil Bio, Inc.
|
TIL
|
Unlock Forecast
|
$182M
|
-1.1x
|
1.3x
|
Tenaya Therapeutics, Inc.
|
TNYA
|
Unlock Forecast
|
$154M
|
-2.5x
|
1.5x
|
Tourmaline Bio, Inc.
|
TRML
|
Unlock Forecast
|
$600M
|
-3.5x
|
2.3x
|
Turnstone Biologics Corp.
|
TSBX
|
Unlock Forecast
|
$8M
|
-0.1x
|
0.6x
|
Taysha Gene Therapies, Inc.
|
TSHA
|
Unlock Forecast
|
$851M
|
-3.0x
|
3.4x
|
TITAN PHARMACEUTICALS INC
|
TTNP
|
Unlock Forecast
|
$8M
|
-0.5x
|
4.5x
|
Tevogen Bio Holdings Inc.
|
TVGN
|
Unlock Forecast
|
$181M
|
x
|
-29.3x
|
Tevogen Bio Holdings Inc.
|
TVGNW
|
Unlock Forecast
|
$11M
|
x
|
-1.9x
|
Twist Bioscience Corp
|
TWST
|
Unlock Forecast
|
$1720M
|
-12.6x
|
3.6x
|
Voyager Acquisition Corp./Cayman Islands
|
VACH
|
Unlock Forecast
|
$-1436M
|
x
|
0.0x
|
Voyager Acquisition Corp./Cayman Islands
|
VACHU
|
Unlock Forecast
|
$-1585M
|
x
|
0.0x
|
Vericel Corp
|
VCEL
|
Unlock Forecast
|
$1868M
|
262.8x
|
6.1x
|
Vigil Neuroscience, Inc.
|
VIGL
|
Unlock Forecast
|
$384M
|
-1.1x
|
9.3x
|
Vir Biotechnology, Inc.
|
VIR
|
Unlock Forecast
|
$636M
|
-2.0x
|
0.7x
|
VivoSim Labs, INC.
|
VIVS
|
Unlock Forecast
|
$3M
|
x
|
0.3x
|
Vor Biopharma Inc.
|
VOR
|
Unlock Forecast
|
$273M
|
-0.6x
|
3.9x
|
Vaxart, Inc.
|
VXRT
|
Unlock Forecast
|
$80M
|
-0.9x
|
2.4x
|
Voyager Therapeutics, Inc.
|
VYGR
|
Unlock Forecast
|
$201M
|
570.6x
|
0.8x
|
WINDTREE THERAPEUTICS INC /DE/
|
WINT
|
Unlock Forecast
|
$18M
|
-0.4x
|
4.2x
|
X4 Pharmaceuticals, Inc
|
XFOR
|
Unlock Forecast
|
$8M
|
6.4x
|
0.4x
|
Zivo Bioscience, Inc.
|
ZIVO
|
Unlock Forecast
|
$70M
|
-31.3x
|
-2.0x
|
Zura Bio Ltd
|
ZURA
|
Unlock Forecast
|
$131M
|
5.0x
|
0.9x
|